PREcision Care, Interventions, Screening, and Empowerment” (PRECISE) risk-stratified PCa screening strategy that will:
 

1) tailor screening strategies for men at elevated PCa risk,

2) Reduce screening related comorbidities and overtreatment,

3) Reduce disparities in prostate cancer mortality.

Through PRECISE implementation, we aim to reduce routine screenings for patients for whom the potential harms outweigh potential benefits, provide tools and enable conversations to help men make better screening decisions about their healthcare based on the value that will reduce prostate cancer disparities.

PRECISE Group Resources

Implementation Sciences

WELCOME TO THE PRECISE HOME PAGE!

MADCaP Network
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215

Supported by Dana-Farber Cancer Institute

MADCaP is grant-funded by the National Cancer Institute

© Copyright 2016-2020 

Dana-Farber Cancer Institute.

Use of MADCaP is subject to our terms of use and our privacy policy.

NCI_Stacked_COLOR.png
img-logo-2x-new.png